This inventor holds 1 USPTO granted patent. Top assignee: Index Pharmaceuticals Ab. Active years: 2006.
Company Filing History:
Years Active: 2006
Title: Jaqueline McGuire: Innovator in Cancer Research
Introduction
Jaqueline McGuire is a prominent inventor based in Huddinge, Sweden. She has made significant contributions to the field of cancer research through her innovative work. Her research focuses on developing tools that enhance the understanding of cancer mechanisms and potential treatments.
Latest Patents
Jaqueline McGuire holds a patent for a "Transgenic mouse expressing constitutively active hydrocarbon receptor." This invention provides powerful tools for studying cancer, particularly through a novel expression construct for a constitutively active hydrocarbon receptor, CA-AhR. The patent includes transgenic non-human animals, preferably mammals, that express CA-AhR in various tissues. This animal model serves as a basis for novel methods in cancer research, including the screening of drug candidates and the investigation of molecular mechanisms related to stomach cancer and highly differentiated adenocarcinoma.
Career Highlights
Jaqueline McGuire is associated with Index Pharmaceuticals AB, where she continues her groundbreaking research. Her work has positioned her as a key figure in the development of innovative cancer research methodologies.
Collaborations
Jaqueline collaborates with notable colleagues, including Lorenz Poellinger and Annika Hanberg Wiklund. Their combined expertise contributes to advancing cancer research and developing effective therapeutic strategies.
Conclusion
Jaqueline McGuire's contributions to cancer research through her innovative patent and collaborations highlight her role as a leading inventor in the field. Her work continues to pave the way for new discoveries and advancements in understanding cancer.